PHARMA EVIDENCE ApS

CVR 34586519Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)FarumFounded 29 May 2012

Employees

CVR registry, 2023

Gross profit

64K

DKK, annual report 2025

Result

+62,1K

DKK, annual report 2025

Equity

134,4K

DKK, annual report 2025

Who Is Behind It

Owner: HB World Holding ApSCVR 39868776, 100% of capital and votes, since 17 Sep 2018
Ultimate controller: Tove Holm-Larsenthrough HB World Holding ApS, a Dandex estimate, owner-managed
Director: Tove Holm-Larsensince 29 May 2012

Ownership

HB World Holding ApS
CVR 39868776100% of capital and votessince 17 Sep 2018

Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.

Former owners (1)

Tove Holm-Larsen
100% of capital and votes29 May 2012 to 17 Sep 2018

Control Chain

Ultimate controller
Tove Holm-Larsen
Holds 100% of capital and votes in HB World Holding ApS, since 17 Sep 2018
Capital100%
Votes100%
Holding company
HB World Holding ApS
CVR 39868776Private limited company (ApS)
Holds 100% of capital and votes in PHARMA EVIDENCE ApS, since 17 Sep 2018
Capital100%
Votes100%
This company
PHARMA EVIDENCE ApS
CVR 34586519

Each holds the one below it. Control follows votes: an owner with 50% or more controls. Each bar shows the registered band, solid to its lower bound and faint across the range CVR records, with a mark at 50%. Dandex estimate, computed 20 Oct 2026.

People

Current (1)

Tove Holm-LarsenExecutive board since 29 May 2012

Founders (1)

Tove Holm-LarsenFounded 29 May 2012, holds a current role

CVR records founders at incorporation. It does not record whether they are alive or still involved.

Network

CompanyPersonShared by two or more of its peopleThicker lines are ownershipSource: CVR, read 20 Oct 2026. Each current person is followed to their other current roles, at most 10 companies each. Their own people are not drawn.

The Network as a List

Its people and their other companies

Tove Holm-Larsen Executive board
- HB World Holding ApS CVR 39868776, Owner, Executive board
- Silvi.ai ApS CVR 40054626, Executive board

Network

Roles Over Time

Tove Holm-Larsen: Executive board, 29 May 2012 to today.

29 May 2012 to 20 Oct 2026.

Executive board (Direktion)Each bar is one role, from its start to its end or today. Bars in a group share one scale. Source: CVR.

Financials

Annual report figures by year, DKK thousands
Metric	2021	2022	2023	2024	2025
Gross profit	196	552	-428	-158	64
Operating profit	-448	+140	-810	-185	+62
Result for the year	-442	+197	-796	-180	+62
Equity	851	1.048	252	72	134
Total assets	1.320	1.268	784	212	282
Employees (average)	1	1	1	0	0

DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.

Annual Reports

Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 16 Jun 2026
XHTML
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 6 Jun 2025
PDF
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 23 Apr 2024
PDF
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 27 Mar 2023
PDF
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 1 Jun 2022
PDF

Changes

Dandex has recorded no changes to this company since it began following the register.

Registration

Address: Sommervej 9
3520 Farum
Furesø Municipality
CVR record last changed: 22 May 2025
Data read: 20 Oct 2026

Production Units

1 registered in CVR.

PHARMA EVIDENCE ApS
P-number 1017707759Sommervej 9, 3520 Farum

Source: the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen. Annual reports via XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.

Ask About PHARMA EVIDENCE ApS With AI

Connect Dandex to Claude, ChatGPT or Cursor to compare years, check credit and map the people around a company.

Set Up MCP Try the Chat Demo